Sentences with phrase «kidney transplantation»

• Women were less likely to want to undergo living donor kidney transplantation compared with men (58.5 % vs 87.5 %) despite being nearly twice as likely as men to receive unsolicited offers for kidney transplants from family and friends (73.2 % vs 43.2 %).

Direct - acting antiviral prophylaxis in kidney transplantation from Hepatitis C virus - infected donors to noninfected recipients: an open - label nonrandomized trial.

However, delayed organ function after kidney transplantation is reported in up to 40 percent of recipients and associated with increased cost and diminished long - term organ function.

For example, in Hanover I established the new Interdisciplinary Transplant Center for Clinical Research, the most experienced center for kidney transplantation in Germany.

In more than a third of kidney transplantations performed in the United States, the transplanted organs come from live donors.

«Diabetic patients who undergo kidney transplantation can expect outcomes equally as successful as nondiabetics, provided that they are diligent in their management of blood pressure, glucose, healthy weight, and other factors that influence their kidney function and overall well - being.»

Even with kidney transplantation, the plan comes very handy and helps greatly with the same.

Stanley C. Jordan, MD, medical director of the Kidney Transplant Program at Cedars - Sinai, said the enzyme is the only one that can completely remove organ - rejecting antibodies and allow kidney transplantation to take place.

The drug «may allow successful kidney transplantation even in patients who are usually excluded from transplant,» said Benedetti.

You can learn more about kidney transplantation at UAB here.

I started my career in nursing in the Memorial Hospital and served there for two years, and now I have been working at Refined Kidney Transplantation Center since 2009.

The most common therapy is a restrictive diet, but doctors must resort to dialysis or kidney transplantation when the disease progresses.

Dr. Víctor Díez Nicolás (associated member, European Society for Transplantation in Urology, ESTU) will present the results of this ESTU - led survey on kidney donation rates and kidney transplantation rates across Europe for 2014.

«This study is important because it has the potential to change the way we approach kidney transplantation,» says the study's principal investigator, E. Steve Woodle, MD, UC Health transplant surgeon and director of the division of transplantation at the UC College of Medicine, who adds: «This also may benefit 10 to 20 percent of heart and pancreas transplant candidates who often have such high levels of antibodies that transplantation is nearly impossible.»

However, they assert that the benefit to patients who would otherwise have had little chance of kidney transplantation far outweigh the concerns.

He developed new techniques for transplant surgery, helped to make kidney transplantation viable and was one of the first researchers to try xenografts — in the 1960s he placed baboon kidneys in six patients.

Research has shown that kidney transplantation results in longer survival, better quality of life, and long - term cost savings compared with dialysis for patient with kidney failure.

Emory scientists have identified troublemaker cells — present in some patients before kidney transplantation — that are linked to immune rejection after transplant.

Freedman, Barry I., et al. «APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.»

Kidney transplantation dated back on average 81 months (SD = 56, range 1 — 330); 354 patients (67 %) were transplanted once, 41 (10 %) twice, 11 (3 %) thrice and four (1 %) more than thrice.

Many programs offer living donor kidney transplantation but require a completely compatible match.

In the United States alone, about 101,000 patients wait for kidney transplantation.»

In a subset of 6 patients who underwent kidney transplantation, the procedure led to a significant drop in TMAO levels.

Stanley C. Jordan, MD, director of Kidney Transplantation and Transplant Immunology, is a prominent pioneer in designing treatment approaches that have significantly reduce the amount of antibodies, thereby reducing the risk of organ rejection.

Known for groundbreaking work in kidney transplantation, our expert physicians and scientists are behind several innovations that have become national standards of care.

Prevalence of end - stage kidney disease — the last stage of chronic kidney disease when the kidneys can no longer remove waste and excess water from the body, and dialysis or kidney transplantation is necessary for survival — continued to rise.

The findings, which are from a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), suggest that interventions are needed to increase women's acceptance of living donor kidney transplantation.

• After controlling for various factors known to influence transplant decisions, women were 87 % less likely to want to undergo living donor kidney transplantation than men.

«In addition, it may allow us to consider organs we may otherwise reject, especially at the extremes of age, which would result in more patients benefiting from kidney transplantation.

Living donor kidney transplantation is the treatment of choice for patients with kidney failure, but disparities exist among certain groups including blacks and women.

«To help improve the gender disparities in living donor kidney transplantation, future work is needed to learn how to support and encourage women to accept transplants,» said Dr. Gillespie.

«Information gained about the concerns and attitudes of hemodialysis patients regarding living donor kidney transplantation might help us develop targeted interventions designed to alleviate some existing disparities,» said Dr. Gillespie.

Patients with end - stage kidney disease benefit from treatments such as dialysis and kidney transplantation, but these approaches have several limitations, including the limited supply of compatible organ donors.

Kidney failure leading to the need for dialysis or kidney transplantation is a major burden to the health care system.

In 2015, 87,538 patients with end - stage renal disease died while on dialysis (16.3 percent of all dialysis patients are awaiting kidney transplants), and 18,805 kidney transplantations were performed that same year.

«The lists of patients awaiting a kidney transplantation are lengthy and growing.

«Early referral to transplant evaluation and access to information about living donor kidney transplantation is key to a successful timely transplant and to improved long - term outcomes,» says Mark Stegall, M.D., a professor of surgery at Mayo Clinic and senior author of the manuscript.

Kidney transplantation or renal transplantation is the organ transplant of a kidney in a patient with end - stage renal failure.

Patients with advanced chronic kidney disease (CKD) are often faced with difficult medical choices, such as whether to start dialysis or undergo kidney transplantation, and many patients may not feel ready to make treatment decisions for a variety of reasons.

Findings of a three - year clinical trial led by University of Cincinnati (UC) transplant researchers suggest that a novel pre-operative drug therapy reduces antibodies in kidney patients with greater success than with traditional methods, with the potential to increase the patients» candidacy for kidney transplantation and decrease the likelihood of organ rejection.

«There is an exceptionally high cost and burden of maintenance dialysis therapy and kidney transplantation,» he said.

In severe cases, patients must undergo dialysis or a kidney transplantation to survive.

In addition, the organizations will help educate patients as they prepare for the possibility of end stage renal disease (ESRD) and the necessity for dialysis or kidney transplantation.

The authors draw attention to the significant center - level variation in the listing practice for patients needing simultaneous liver and kidney transplantation.

To go with the paper, NEJM has an editorial with some revealing statistics (more than 14,000 of the 101,000 patients listed for kidney transplantation are waiting for a repeat transplant) and a explanatory video. MedPage Today has an interview with Larsen, and HealthDay has a nice discussion of the issues surrounding post-transplant drugs.

Autosomal dominant medullary cystic kidney disease 1 (MCKD1) is a rare hereditary renal disease that ultimately requires dialysis or kidney transplantation for patients.

General surgery, Hepatobiliary surgery, Liver, intestine and kidney transplantation, Minimally invasive surgery, Neonatal surgery, Oncologic surgery, Thoracic surgery